Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIB Randomized, Open Label, Two Arms and Parallel Group Clinical Trial to Assess the Efficacy and Safety of FIRTECH (Infrared Therapy Patch), for Treating Patients Suffering From Mild to Moderate Acute Low Back Pain

NCT05137041 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05137041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIB Randomized, Open Label, Two Arms and Parallel Group Clinical Trial to Assess the Efficacy and Safety of FIRTECH (Infrared Therapy Patch), for Treating Patients Suffering From Mild to Moderate Acute Low Back Pain
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 4, 2021
Completion date
November 22, 2022
Enrollment
221 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.